Money Talks: Pfizer’s COVID Vaccine Hits Record Number of Sales
Pfizer announced that the COVID-19 vaccine it makes with BioNTech registered a staggering $36.8 billion of sales in 2021.
The Pfizer/BioNTech COVID-19 vaccine is now the top-selling pharmaceutical product ever in a single year, by a wide margin.
Axios reported that Humira was the next highest, with $20.7 billion reported in 2021.
Pfizer expects that the vaccine will generate another $32 billion of sales this year, and the company’s new antiviral COVID pill, Paxlovid, will net $22 billion.
Despite the record-breaking revenue, Pfizer’s stock fell more than 5% because Wall Street had expected even higher numbers.